Sensibilización alérgica de contacto en pacientes con rosácea

Magdaleno‐Tapial, Jorge; López-Martí, Cristina; García-Legaz-Martínez, Marta; Martínez‐Doménech, Álvaro; Partarrieu-Mejías, Felipe; Casanova-Esquembre, A.; Lorca-Spröhnle, J.; Labrandero-Hoyos, C.; Peñuelas-Leal, R.; Talamantes, Concepción Sierra; Pérez‐Ferriols, A.; Zaragoza‐Ninet, Violeta

doi:10.1016/j.ad.2022.02.026

Cited by 6 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Acne rosacea is a chronic inflammatory acne-like dermatosis that occurs in the mid-face area and manifests as transient erythema, redness, pustules, and papules [174]. To date, the direct cause is not known; however, the mechanisms affecting this disease may include changes in the immune response [175].…”

Section: Acne Rosaceamentioning

confidence: 99%

Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Diseases Related- Current State of Knowledge

Roszkowska,

Klimczak,

Ostrycharz

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

Section: Acne Rosaceamentioning

confidence: 99%

Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Diseases Related- Current State of Knowledge

Roszkowska,

Klimczak,

Ostrycharz

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Acne rosacea is a chronic inflammatory acne-like dermatosis that occurs in the midface area and manifests as transient erythema, redness, pustules, and papules [176]. The direct cause is unknown at present; however, the mechanisms affecting this disease may include changes in the immune response [177].…”

Section: Acne Rosaceamentioning

confidence: 99%

Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge

Roszkowska,

Klimczak,

Ostrycharz

et al. 2024

Biomedicines

View full text Add to dashboard Cite

The human gut microbiota creates a complex microbial ecosystem, characterized by its high population density, wide diversity, and complex interactions. Any imbalance of the intestinal microbiome, whether qualitative or quantitative, may have serious consequences for human health, including small intestinal bacterial overgrowth (SIBO). SIBO is defined as an increase in the number of bacteria (103–105 CFU/mL), an alteration in the bacterial composition, or both in the small intestine. The PubMed, Science Direct, Web of Science, EMBASE, and Medline databases were searched for studies on SIBO and related diseases. These diseases were divided into 12 groups: (1) gastrointestinal disorders; (2) autoimmune disease; (3) cardiovascular system disease; (4) metabolic disease; (5) endocrine disorders; (6) nephrological disorders; (7) dermatological diseases; (8) neurological diseases (9); developmental disorders; (10) mental disorders; (11) genetic diseases; and (12) gastrointestinal cancer. The purpose of this comprehensive review is to present the current state of knowledge on the relationships between SIBO and these 12 disease groups, taking into account risk factors and the causal context. This review fills the evidence gap on SIBO and presents a biological–medical approach to the problem, clearly showing the groups and diseases having a proven relationship with SIBO, as well as indicating groups within which research should continue to be expanded.

show abstract

Value Proposition of Epicutaneous Patch Testing: A Win-Win for the Patient and the Medical System

Patel,

Hamann,

Hamann

2024

Curr Derm Rep

View full text Add to dashboard Cite

Sensibilización alérgica de contacto en pacientes con rosácea

Cited by 6 publications

References 14 publications

Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Diseases Related- Current State of Knowledge

Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Diseases Related- Current State of Knowledge

Small Intestinal Bacterial Overgrowth (SIBO) and Twelve Groups of Related Diseases—Current State of Knowledge

Value Proposition of Epicutaneous Patch Testing: A Win-Win for the Patient and the Medical System

Contact Info

Product

Resources

About